Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Del Brutto, O. H.
Right arrow Articles by Mosquera, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Del Brutto, O. H.
Right arrow Articles by Mosquera, A.
Neurology 1999;52:1079
© 1999 American Academy of Neurology
Brief Communications

Single-day praziquantel versus 1-week albendazole for neurocysticercosis

Oscar H. Del Brutto, MD, Xavier Campos, MD, Javier Sánchez, MD and Aurelio Mosquera, MD

From the Department of Neurology, Luis Vernaza Hospital, Guayaquil, Ecuador.

Address correspondence and reprint requests to Dr. Oscar H. Del Brutto, Air Center 3542, PO Box 522970, Miami, FL 33152-2970.

The efficacy of albendazole (15 mg/kg/d for 1 week) was compared with praziquantel (100 mg/kg in three divided doses at 2-hour intervals) for therapy of parenchymal brain cysticercosis. Ten patients were treated with albendazole and 10 patients with praziquantel. Although the total number of cysts was significantly reduced from 64 to 7 in patients treated with albendazole and from 59 to 24 in those treated with praziquantel, the number of patients improving with albendazole was not significantly different from those treated with praziquantel.




This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
O. H. Del Brutto, K. L. Roos, C. S. Coffey, and H. H. Garcia
Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel
Ann Intern Med, July 4, 2006; 145(1): 43 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
H. H. Garcia, C. A. W. Evans, T. E. Nash, O. M. Takayanagui, A. C. White Jr., D. Botero, V. Rajshekhar, V. C. W. Tsang, P. M. Schantz, J. C. Allan, et al.
Current Consensus Guidelines for Treatment of Neurocysticercosis
Clin. Microbiol. Rev., October 1, 2002; 15(4): 747 - 756.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Lopez-Gomez, N. Castro, H. Jung, J. Sotelo, and T. Corona
Optimization of the single-day praziquantel therapy for neurocysticercosis
Neurology, November 27, 2001; 57(10): 1929 - 1929.
[Full Text] [PDF]

Home page
 NeurologyHome page
O. H. Del Brutto, V. Rajshekhar, A. C. White Jr., V. C. W. Tsang, T. E. Nash, O. M. Takayanagui, P. M. Schantz, C. A. W. Evans, A. Flisser, D. Correa, et al.
Proposed diagnostic criteria for neurocysticercosis
Neurology, July 24, 2001; 57(2): 177 - 183.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
G. Y. Chang, D. Y. Ko, G. Hagemann, O. W. Witte, and B. Gottstein
Isolated Echinococcus granulosus hydatid cyst in the CNS with severe reaction to treatment
Neurology, February 8, 2000; 54(3): 778 - 778.
[Full Text] [PDF]

Home page
 NeurologyHome page
H. H. Garcia and O. H. Del Brutto
Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers
Neurology, October 22, 1999; 53(7): 1582 - 1582.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.